LifeVantage Expands Global Reach with International Launch of the MB System™

Core Insights - LifeVantage Corporation is expanding its MindBody GLP-1 System™ to international markets following a 49% year-over-year revenue increase in fiscal Q2 2024 in the U.S. driven by the system's success [1][2] - The global GLP-1 pharmaceutical market was valued at $53.46 billion in 2024 and is projected to grow at a CAGR of 17.5$156.71 billion by 2030 [3][4] Group 1: Product Launch and Market Expansion - The MB System™ launched on March 15, 2025, in Japan and became available exclusively to Consultants in Australia, New Zealand, Europe, the UK, Mexico, and Thailand, with customer access starting April 25 [2][5] - Future market expansions include launches in the Philippines and Taiwan in summer 2025, followed by Canada later in the year [5] Group 2: Health Benefits and Consumer Demand - The MB System™ is designed to naturally activate the body's GLP-1 production, offering long-term health benefits beyond weight management, aligning with the growing consumer demand for sustainable health solutions [2][4] - The focus on holistic wellness and metabolic health is increasing, with the MB System™ supporting metabolism, gut health, and hormone function, which are essential for long-term health [4]